Durata Therapeutics, Inc. (NASDAQ: DRTX) Shares Soar on Takeover Offer: U.S. Daily Market Movers

Published:

Small
cap stocks making big moves on Monday, October 6, 2014 (as of 4 pm EST), as
reported by Sean Mason, SmallCapPower.com

Durata Therapeutics, Inc. (NASDAQ: DRTX)
shares shot up 75% to $24.24 on volume of more than 7.9 million shares Monday
after the pharmaceutical company said it has agreed to be acquired by Actavis plc (NYSE: ACT)
for $23 per share in cash, or a total consideration of approximately $675
million. Durata shareholders could also receive up to an additional $5 per
share if certain regulatory and commercial targets are met for Dalvance, which
an IV antibiotic for acute bacterial skin and skin structure infections.

As well,
shares of GT Advanced Technologies Inc. (NASDAQ: GTAT)
plunged 93% to $0.80 on more than 177.6 million shares traded as the supplier of
sapphire glass to Apple Inc. (NASDAQ: AAPL)
announced that it had filed for voluntary bankruptcy protection. Last month it
was revealed that the company’s scratch-resistant glass was left out of Apple’s
new large-screen iPhones.

Unilife Corporation (NASDAQ: UNIS),
meanwhile, reported the signing of a worldwide Master Services and Commercial
Supply Agreement with Sanofi to be the sole provider of cartridge based
wearable injectors for all of Sanofi’s applicable large dose volume drugs,
excluding insulins, for a minimum 15 years. Unilife is a developer and supplier
of injectable drug delivery systems. Its stock popped 24% to $2.69 following
the announcement.

Finally,
Revolution Lighting Technologies, Inc.
(NASDAQ: RVLT)
shares jumped 16% to $1.89 after the provider of advanced LED lighting
solutions said revenue in the third quarter of 2014 is expected to exceed $26
million, as compared to $5.3 million in the third quarter of 2013.  

Related articles

Recent articles